Atropine
Atropin Accord, Atropinsulfat Aguettant, Atropinsulfat Inresa, Atropinsulfat Noridem · ATC code A03BA01
Also known as: Atropin, Atropina, Atropine Sulfate · Brand names: Atropin-Pos, Atropinsulfat Aguettant, Atropinsulfat B. Braun, Atropinsulfat Dr. Franz Köhler Chemie Gmbh, Atropinsulfat Inresa, Atropinsulfat Noridem Enterprises, Atropinsulfat Smartpractice Europe, Atropinum Sulfuricum Eifelfango, Dysurgal, Rafaject, Atropin Accord, Atropinsulfat Noridem, Atropinum Sulfuricum "evolan", Atropinum Sulfuricum Evolan, Atropin Sulfat Biofarma …
- Key facts
- Active substance
- Atropine
- ATC code
- A03BA01
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-11-06
Key facts
Atropine is an antimuscarinic (anticholinergic) agent. Per the US label the intravenous injection is used for temporary blockade of severe or life-threatening muscarinic effects.
What it is used for
- Antisialagogue and antivagal agent
- Antidote for organophosphorus or muscarinic mushroom poisoning
- Bradyasystolic cardiac arrest
Dosing
- Intravenous; titrate to heart rate, PR interval, blood pressure and symptoms
- Antisialagogue or other antivagal use: 0.5 to 1 mg, repeat every 1-2 hours
- Organophosphorus or muscarinic mushroom poisoning: 2 to 3 mg, repeat every 20-30 minutes
- Bradyasystolic cardiac arrest: 1 mg, repeat every 3-5 minutes; 3 mg maximum total dose
- Children: not well studied; usual initial dose 0.01 to 0.03 mg/kg
- Coronary artery disease: limit the total dose to 0.03 mg/kg to 0.04 mg/kg
Contraindications
- None stated in the label
Important warnings
- Tachycardia increases myocardial oxygen demand in coronary artery disease
- May precipitate acute glaucoma
- May turn partial pyloric stenosis into complete obstruction
- Complete urinary retention in prostatic hypertrophy
- Viscid bronchial plugs in chronic lung disease
Side effects
- Dry mouth, blurred vision, photophobia, tachycardia
- Anhidrosis with heat intolerance
- Constipation and difficulty in micturition in elderly patients
- Hypersensitivity reactions, mainly skin rashes, occasionally progressing to exfoliation
Interactions
- Mexiletine: slower absorption, oral bioavailability unchanged
Pregnancy and breastfeeding
- Data insufficient to evaluate risk; atropine crosses the placenta; life-sustaining therapy should not be withheld
- Trace amounts in human milk; pumping and discarding milk for 24 hours after use minimises infant exposure
Summary of the official product information, written with AI on 2026-11-14. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Germany
- Atropin-PosUrsapharm Arzneimittel Gmbh · 1 register entry
- Atropinsulfat AguettantLaboratoire Aguettant · 1 register entry
- Atropinsulfat B. BraunB.Braun Melsungen Ag · 1 register entry
- Atropinsulfat Dr. Franz Köhler Chemie GmbhDr. Franz Köhler Chemie Gmbh · 1 register entry
- Atropinsulfat InresaInresa Arzneimittel Gmbh · 1 register entry
- Atropinsulfat Noridem EnterprisesNoridem Enterprises Ltd · 1 register entry
- Atropinsulfat Smartpractice EuropeSmartpractice Europe Gmbh · 1 register entry
- Atropinum Sulfuricum EifelfangoEifelfango Chem. Pharm. Werk Gmbh & Co. Kg · 1 register entry
- DysurgalMaxmedic Pharma Gmbh. · 1 register entry
- RafajectActrevo Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-06
Austria
- Atropin AccordAccord Healthcare B.V. · 1 register entry
- Atropinsulfat AguettantLaboratoire Aguettant · 2 register entries
- Atropinsulfat InresaInresa Arzneimittel Gmbh · 1 register entry
- Atropinsulfat NoridemNoridem Enterprises Ltd · 1 register entry
- Atropinum Sulfuricum "evolan"Evolan Pharma Ab · 1 register entry
- Atropinum Sulfuricum EvolanEvolan Pharma Ab · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-06
Turkey
- Atropin Sulfat BiofarmaBİOFARMA İLAÇ SAN. VE TİC. A.Ş. · 5 register entries
- Atropin SülfatGALEN İLAÇ SAN.VE TİC.A.Ş, BİOFARMA İLAÇ SAN. VE TİC. A.Ş., ONFARMA İLAÇ SAN. LTD. ŞTİ., OSEL İLAÇ SAN. VE TİC. A.Ş. · 16 register entries
- Drogsan Atropin SulfatDROGSAN İLAÇLARI SAN. VE TİC. A.Ş. · 5 register entries
- Drogsan Atropin SülfatDROGSAN İLAÇLARI SAN. VE TİC. A.Ş. · 1 register entry
- Turktipsan Atropin SülfatTURKTIPSAN SAĞLIK TURİZM EĞİTİM VE TİC. A.Ş. · 6 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-11-06
Brand names in 26 more European countries
- Belgium
- Atropine Alcon, Atropine Sulfate Aguettant, Atropine Sulfate Noridem, Atropine Sulfate Sterop
- Bulgaria
- Атропин Вижън, Атропин Софарма
- Cyprus
- Atropine Sulfate, Atropine Αρητη, Ατροπινη Θειικη Demo
- Czechia
- Atropin Bbp, Atropin-Pos, Atropine Noridem
- Denmark
- Atropin Abboxia, Atropin Aguettant, Atropin Sad, Atropine Accord, Atropine Noridem, Rafaject
- Estonia
- Atropine Auxilia, Atropine Basi
- Finland
- Atropin Abboxia, Atropin Aguettant, Atropin Evolan Pharma Ab, Atropine Accord, Atropine Noridem, Atropine Sulphate Minims Bausch & Lomb U.K.
- France
- Atropine (Sulfate) Aguettant, Atropine (Sulfate) Pharmacie Centrale Des Armees, Atropine Alcon, Atropine Faure, Atropine Sulfate Accord, Atropine Sulfate Aguettant, Atropine Sulfate Noridem, Atropine Sulfate Renaudin
- Greece
- Atropine Sulfate Bradex, Atropine Sulfate Cooper, Atropine Αρητη, Trapinject, Ατροπινη Θειικη Demo Abee
- Hungary
- Atropine Sulphate Noridem, Atropinum Sulfuricum Egis
- Iceland
- Atropin Abboxia, Atropin Viatris, Ryjunea
- Ireland
- Atropine Sulfate Aguettant, Minims
- Italy
- Atropina Farmigea, Atropina Solfato Accord, Atropina Solfato Aguettant, Atropina Solfato Bioindustria L.I.M., Atropina Solfato Galenica Senese, Atropina Solfato Laboratoire Aguettant, Atropina Solfato Monico, Atropina Solfato Noridem, Atropina Solfato S.A.L.F.
- Latvia
- Atropine Sopharma, Atropine Sulfate Basi
- Liechtenstein
- Ryjunea
- Lithuania
- Atropine Sulfate Basi
- Luxembourg
- Alcon, Atropine (Sulfate) Noridem, Atropine Sulfate Aguettant, Atropine Sulfate Sterop, Atropinsulfat B. Braun
- Malta
- Minims
- Netherlands
- Atorvastatina Cf, Atropinesulfaat Accord, Atropinesulfaat Aguettant, Atropinesulfaat Cf, Atropinesulfaat Teva, Minims Atropinesulfaat
- Norway
- Atropin Abboxia, Atropin Aguettant, Atropin Evolan Pharma, Atropin Minims Bausch + Lomb Ireland Limited, Atropine Accord, Atropine Noridem, Ryjunea
- Poland
- Atropinum Sulfuricum Wzf, Bellapan, Miofree
- Portugal
- Atropina Accord, Atropina Aguettant, Atropina Basi, Atropina Braun, Atropina Labesfal, Atropina Noridem, Atropocil
- Romania
- Sulfat De Atropină Accord, Sulfat De Atropină Evolan, Sulfat De Atropină Noridem
- Slovakia
- Atropin Bbp, Atropine Noridem
- Spain
- Atropina Accord, Atropina Aguettant, Atropina B. Braun, Atropina Noridem, Atropina Sulfato Aguettant, Atropina Sulfato Serra Pamies, Atropine Sulfate Aguettant, Colirofta Atropina
- Sweden
- Atropin Abboxia, Atropin Aguettant, Atropin Bausch & Lomb, Atropin Viatris, Atropine Accord, Atropine Noridem
EMA – Article 57 product data (EU/EEA), 2026-11-06
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Atropine Sulfate (Hospira, Inc.) – Prescribing Information, 2026-05-18. DailyMed (NLM), 2026-11-06. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad8916e7-206e-409e-2582-30d072845dd4
- EMA – Article 57 product data (EU/EEA), 2026-11-06. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-11-06. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-11-06. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-11-06 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.